AKAP9 (A-Kinase Anchoring Protein 9) is a Protein Coding gene. Diseases associated with AKAP9 include Long Qt Syndrome 11 and Long Qt Syndrome 1. Among its related pathways are RET signaling and Regulation of PLK1 Activity at G2/M Transition. Gene Ontology (GO) annotations related to this gene include signaling receptor binding and ion channel binding. An important paralog of this gene is PCNT.
CUSABIO produces high-quality anti-AKAP9 antibodies (includes polyclonal antibodies, monoclonal antibodies, recombinant antibodies) in house with strict quality control. And they can help you discover more in your research.
These AKAP9 antibodies are validated in multiple tissues with various applications and covering a broad range of life science research and drug development. They are featured with high specificity, multiple epitopes recognition, and wide species reactivity. Moreover, CUSABIO provides various options on sizes, excellent technical support and AKAP9 antibodies custom service.
AKAP9 Antibodies for Homo sapiens (Human)
|Code||Product Name||Species Reactivity||Application|
|CSB-PA857882LA01HU||Human||ELISA, WB, IHC, IF|